Últimas noticias sobre MKS Instruments (NASDAQ:MKSI) Bolsa

MKS Instruments

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

MKS Instruments Inc

WIIM

ACLS

AEHR

ALAB

ALGM

AMAT

AMBA

ASML

CRDO

ENPH

ENTG

INDI

INTC

KLAC

LRCX

LSCC

MCHP

MKSI

MPWR

MRVL

MTSI

NXPI

QCOM

RMBS

SITM

SLAB

SMTC

Shares of semiconductor companies are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Stifel raised the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) from $490 to $494. Stifel analyst Paul Matteis maintained a Hold rating. Vertex Pharmaceuticals shares closed at $463.73 on Friday. See how other analysts view this stock.</li>
<li>Jefferies raised the price target for Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) from $63 to $70. Jefferies analyst Akash Tewari upgraded the stock from Hold to Buy. Bristol-Myers Squibb shares closed at $55.78 on Friday. <a href="https://www.benzinga.com/quote/BMY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer boosted the price target for Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) from $825 to $1,065. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Netflix shares closed at $918.87 on Friday. <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut MKS Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) price target from $155 to $150. Morgan Stanley analyst Joseph Moore maintained an Overweight rating. MKS Instruments shares settled at $112.55 on Friday. <a href="https://www.benzinga.com/quote/MKSI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital raised RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) price target from $320 to $450. Loop Capital analyst Anthony Chukumba maintained a Hold rating. Walmart shares closed at $446.04 on Friday. <a href="https://www.benzinga.com/quote/RH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) price target from $92 to $82. Deutsche Bank analyst Krisztina Katai maintained a Buy rating. NIKE shares closed at $77.25 on Friday.  <a href="https://www.benzinga.com/quote/NKE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt raised The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) price target from $122 to $135. Rosenblatt analyst Barton Crockett maintained a Buy rating. Disney shares closed at $113.34 on Friday. See how other analysts view this stock.</li>
<li>Mizuho cut the price target for Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) from $137 to $134. Mizuho analyst Nitin Kumar maintained a Neutral rating. Exxon Mobil shares settled at $110.84 on Friday. <a href="https://www.benzinga.com/quote/XOM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho raised CNX Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNX#NYSE">CNX</a>) price target from $33 to $38. Mizuho analyst Nitin Kumar downgraded the stock from Neutral to Underperform. CNX Resources shares closed at $37.79 on Friday. <a href="https://www.benzinga.com/quote/CNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush raised Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) price target from $400 to $515. Wedbush analyst Daniel Ives maintained an Outperform rating. Tesla shares closed at $436.23 on Friday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying TSLA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="483" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16083522/image-126-1024x483.png" alt="" class="wp-image-693891" style="width:557px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16083522/image-126-1024x483.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16083522/image-126-300x142.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16083522/image-126-768x362.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16083522/image-126.png 1176w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

NFLX

TSLA

VRTX

Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

Morgan Stanley analyst Joseph Moore maintains MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) with a Overweight and lowers the price target from $155 to $150.

Morgan Stanley Maintains Overweight on MKS Instruments, Lowers Price Target to $150

Shares of MKS Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) have lost more than <a href="https://www.benzinga.com/quote/mksi">17% over the past six months</a>.
The company is a market leader in 20 product categories and has a "strong set of tier-1 customers," according to JPMorgan.
Analyst Peter Peng initiated coverage of MKS Instruments with an Overweight rating and a price target of $145.
The MKS Instruments Thesis: The company is well positioned to benefit from strong wafer fabrication equipment spending in advanced logic, "combined with major technology inflections such as advanced packaging, high bandwidth memory, gate-all-around transistors, and backside power distributions," Peng said in the initiation note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
MKS Instruments is "gaining traction in process control and lithography applications due to its optical and optical subsystems, precision motion, and laser product lines," the analyst stated. While the company historically had less exposure in these areas, it now seems well positioned for market share gains, he added.
MKS Instruments is likely to generate mid- to high- single-digit percentage revenue growth, "driven by its differentiated advanced technology/IP portfolio, market share gains, and strong exposure to the secular growth in WFE and advanced packaging," Peng further wrote.
MKSI Price Action: Shares of MKS Instruments were down 0.78% to $112.02 at the time of publication on Friday.
Read More:
<ul>
<li><a href="https://www.benzinga.com/content/40478070/coherent-sees-strong-ai-tailwinds-for-its-optical-business">Coherent Sees Strong AI Tailwinds For Its Optical Business</a></li>
</ul>
Photo: Matveev Aleksandr/Shutterstock.com

Analyst Color

Long Ideas

Initiation

Tech

MKS Instruments Is 'Gaining Traction' In Advanced Technologies, Analyst Says

JP Morgan analyst Peter Peng initiates coverage on MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) with a Overweight rating and announces Price Target of $145.

JP Morgan Initiates Coverage On MKS Instruments with Overweight Rating, Announces Price Target of $145

During the last three months, 4 analysts shared their evaluations of MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $128.0, a high estimate of $142.00, and a low estimate of $110.00. Highlighting a 5.65% decrease, the current average has fallen from the previous average price target of $135.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1731949387_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of MKS Instruments's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$142.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Joseph Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$110.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$140.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MKS Instruments. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MKS Instruments compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of MKS Instruments's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MKS Instruments's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MKSI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MKS Instruments analyst ratings.</a>
<h2>About MKS Instruments</h2>
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.
<h3>Breaking Down MKS Instruments's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining MKS Instruments's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -3.86% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: MKS Instruments's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.92% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): MKS Instruments's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.68% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): MKS Instruments's ROA stands out, surpassing industry averages. With an impressive ROA of 0.69%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: MKS Instruments's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.11, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying MKS Instruments: Insights From 4 Analyst Reviews

Benchmark analyst Mark Miller reiterates MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) with a Buy and maintains $142 price target.

Reiteration

Benchmark Reiterates Buy on MKS Instruments, Maintains $142 Price Target

AVGO

NVDA

Shares of semiconductor and chip stocks are trading lower in sympathy with Applied Materials, which fell after its Q1 financial results.

MKS Instruments shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 adjusted EPS results above estimates.

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) is looking for Q4 Adj EPS of $1.63-2.27 vs $1.49 analyst estimate. sees sales of $870.000 million-950.000 million vs $885.04 million estimate.

Guidance

MKS Instruments Sees Q4 Adj EPS $1.63-2.27 vs $1.49 Est; Sees Sales $870.000M-950.000M vs $885.04M Est.

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) reported quarterly earnings of $1.72 per share which beat the analyst consensus estimate of $1.45 by 18.62 percent. The company reported quarterly sales of $896.000 million which beat the analyst consensus estimate of $874.257 million by 2.49 percent. This is a 3.86 percent decrease over sales of $932.000 million the same period last year.

Earnings

Earnings Beats

MKS Instruments Q3 2024 Adj. EPS $1.72 Beats $1.45 Estimate, Sales $896.000M Beat $874.257M Estimate

MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-11-06. Here's what investors need to know before the announcement.
Analysts estimate that MKS Instruments will report an earnings per share (EPS) of $1.45. 
Anticipation surrounds MKS Instruments's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.46, leading to a 6.23% increase in the share price the following trading session.
Here's a look at MKS Instruments's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.07</td>
<td>0.75</td>
<td>0.84</td>
<td>1.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.53</td>
<td>1.18</td>
<td>1.17</td>
<td>1.46</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>3.0%</td>
<td>6.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730833356_0.png" alt="eps graph" />
<h3>Market Performance of MKS Instruments's Stock</h3>
Shares of MKS Instruments were trading at $99.57 as of November 04. Over the last 52-week period, shares are up 44.51%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about MKS Instruments</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on MKS Instruments.
A total of 8 analyst ratings have been received for MKS Instruments, with the consensus rating being Neutral. The average one-year price target stands at $131.25, suggesting a potential 30.47% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Amkor Tech, Onto Innovation and FormFactor, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, Amkor Tech is favoring an Outperform trajectory, with an average 1-year price target of $34.57, suggesting a potential 65.64% downside.</li>
<li>The consensus among analysts is an Buy trajectory for Onto Innovation, with an average 1-year price target of $249.29, indicating a potential 147.8% upside.</li>
<li>As per analysts' assessments, FormFactor is favoring an Buy trajectory, with an average 1-year price target of $48.0, suggesting a potential 52.29% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Amkor Tech, Onto Innovation and FormFactor, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>MKS Instruments</td>
<td>Neutral</td>
<td>-11.57%</td>
<td>$419M</td>
<td>0.99%</td>
</tr>
<tr>
<td>Amkor Tech</td>
<td>Outperform</td>
<td>2.18%</td>
<td>$272.48M</td>
<td>2.98%</td>
</tr>
<tr>
<td>Onto Innovation</td>
<td>Buy</td>
<td>21.73%</td>
<td>$136.38M</td>
<td>2.84%</td>
</tr>
<tr>
<td>FormFactor</td>
<td>Buy</td>
<td>5.29%</td>
<td>$86.90M</td>
<td>1.97%</td>
</tr>
</tbody>
</table>

Key Takeaway:
MKS Instruments ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, MKS Instruments is at the bottom compared to its peers.
<h3>About MKS Instruments</h3>
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.
<h3>MKS Instruments: Financial Performance Dissected</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, MKS Instruments faced challenges, resulting in a decline of approximately -11.57% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 2.59%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): MKS Instruments's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.99%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): MKS Instruments's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.26%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: MKS Instruments's debt-to-equity ratio stands notably higher than the industry average, reaching 2.29. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/MKSI/earnings">To track all earnings releases for MKS Instruments visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into MKS Instruments's Upcoming Earnings

MKS Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>), a global provider of technologies that transform the world, the Malaysian Investment Development Authority (MIDA) and InvestPenang today announced that MKS celebrated the groundbreaking ceremony of its super center factory in Penang, Malaysia to support the growing needs of semiconductor equipment for wafer fabrication in the region and globally. The state-of-the-art facility will be located on a 17-acre plot, spanning approximately 500,000 square feet. and will employ approximately 1,000 people. The new factory will be built in multiple phases, with the first phase scheduled for completion in the first half of 2026.

MKS Instruments Breaks Ground on New 500,000 Sq. Ft. Semiconductor Super Center in Malaysia, 1,000 Jobs Expected

ARM,QCOM,NVDA,MU,AMD,TSM,AVGO,NXPI,LRCX,INTC,ASML,ON,RMBS,LSCC,GFS,TSEM,SIMO,ADI,KLAC,MCHP,STM,AMAT

ACMR

CAMT

FORM

FSLR

KLIC

NVMI

SIMO

TSEM

UCTT

Shares of chip stocks are trading lower in sympathy with ASML, which fell after issuing soft guidance. Some stocks in the sector may also be down on reports indicating the US is discussing curbing chip exports to some countries.

MKS Instruments's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NYSE">MKSI</a>) short percent of float has fallen 18.01% since its last report. The company recently reported that it has 2.44 million shares sold short, which is 4.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>MKS Instruments Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728324019_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MKS Instruments has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MKS Instruments's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, MKS Instruments's peer group average for short interest as a percentage of float is 6.75%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About MKS Instruments?

Wells Fargo analyst Joseph Quatrochi maintains MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) with a Equal-Weight and lowers the price target from $120 to $110.

Wells Fargo Maintains Equal-Weight on MKS Instruments, Lowers Price Target to $110

ACHR

AMBR

AXTI

DIOD

GCTS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBLY

NVTS

SWKS

SYNA

WOLF

Shares of semiconductor and chip stocks are trading higher following strong earnings from Micron.

AMKR

ONTO

Shares of semiconductor companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Citigroup analyst Atif Malik downgrades MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) from Buy to Neutral and lowers the price target from $145 to $120.

Downgrades

Citigroup Downgrades MKS Instruments to Neutral, Lowers Price Target to $120

SMTK

Semiconductor shares are trading higher amid possible sympathy with NVIDIA. At the ABC 2024 Presidential Debate, Vice President Harris said she wants to invest in American-based technology to win the race on AI and quantum computing.

Franklin Convertible Securities Fund Q3 2024 Commentary

Invesco Main Street Mid Cap Fund Q3 2024 Commentary

Invesco Main Street Small Cap Fund Q3 2024 Commentary

Invesco Small Cap Value Fund Q3 2024 Commentary

TMSL: Multi-Factor ETF Off To A Good Start

Morgan Stanley analyst Shane Brett assumed coverage of MKS Instruments (MKSI) with an Overweight rating and $155 price target Following record Wafe...

MKS Instruments assumed with an Overweight at Morgan Stanley

In a report released on December 3, Joseph Quatrochi from Wells Fargo maintained a Hold rating on MKS Instruments (MKSI – Research Report), with a ...

Hold Rating Maintained for MKS Instruments Amid Mixed Demand and Strategic De-Leveraging

JPMorgan initiated coverage of MKS Instruments (MKSI) with an Overweight rating and $145 price target implying 25% upside potential. MKS is a key c...

MKS Instruments initiated with an Overweight at JPMorgan

MKS Instruments gets initiated with bullish views at J.P. Morgan

Morgan Stanley lowered the firm's price target on MKS Instruments (MKSI) to $150 from $155 and keeps an Overweight rating on the shares. After havi...

MKS Instruments price target lowered to $150 from $155 at Morgan Stanley

ADMA

ALSN

ATKR

AXON

BABA

BABAF

BBMC

BKLN

BKNG

BPOP

BPOPO

BURL

CIVI

COHR

CPAY

CQQQ

DXCM

ESAB

EWBC

EXPE

FCPT

FLQM

GRPM

GTLS

GWRE

HUBS

IART

INFA

INSM

INSP

IVPAF

JHMM

KBWB

KBWD

KBWY

LITE

MANH

PCEF

PDBC

PFSI

PINS

PNQI

PODD

PRFZ

PTON

QQQJ

QQQM

QVMM

REXR

RSPT

SMCI

SNAP

SNOW

SOXQ

SPGP

SPHB

SPHD

SPHQ

SPLV

SPMO

TMSL

TSCO

TXRH

WELL

XMHQ

XMMO

Management

Press Releases

Ram Mayampurath to Join MKS Instruments as Chief Financial Officer

MKS Instruments to Participate in Citi's 2024 Global TMT Conference

MKS Instruments CEO to be Honored as Pinnacle Award Winner by the Asian American Business Development Center

Comments

MKS Instruments

Noticias

Últimas noticias sobre MKS Instruments (NASDAQ:MKSI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL